Status:
COMPLETED
Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants
Lead Sponsor:
AdventHealth
Conditions:
Gastric Residual Volume
Preterm Infant
Eligibility:
All Genders
2-1 years
Phase:
NA
Brief Summary
The practice of checking gastric residuals is not evidence based. The amount of gastric residual volume (GRV) does not correlate with either feeding intolerance or development of NEC. We hypothesize t...
Detailed Description
The term "gastric residuals" in neonates refers to aspiration of gastric contents before each feeding in an infant receiving enteral feeding using an intermittent feeding tube. The presence of signifi...
Eligibility Criteria
Inclusion
- Birth weight ≤1250g
- Gestational age of \< 33 weeks
- Expected to receive feeds via gastric tubes
Exclusion
- Death expected within 72 hours of birth
- Major chromosomal or congenital anomaly
- Major GI anomaly such as gastroschisis, spontaneous perforation etc.
Key Trial Info
Start Date :
May 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04062851
Start Date
May 3 2019
End Date
March 31 2022
Last Update
April 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AdventHealth
Orlando, Florida, United States, 32803